Calcium channel blockers (versus unexposed)

Study	Exclusion reasons	Rmk	Reference
Davis - Calcium blockers, 2011	other reason	EXCLUDED: RR provided by authors did not correspond to the RR obtained with raw data => E-mail sent to authors. => No answer => Excluded.	Davis Pharmacoepidemiol Drug Saf 2011; 20:138-45 10.1002/pds.2068
Salama - Nifedipine, 2019	other reason	EXCLUDED: Rezk 2019-Retracted article (Retraction Watch https://retractionwatch.com/) and all studies of the team are suspected 'The assessment of the work of Dr Rezk shows prima facie evidence of data fabrication.	Salama Pregnancy Hypertens 2019; 17:54-58 10.1016/j.preghy.2019.05.009
Vermes - Nifedipine, 2015	same data already obtained by other studies	EXCLUDED: Overlapping: Vermes 2015; Banhidy 2011 and Sorensen 2001 used same database, on the same study period, to study the same outcome => Sorensen 2001 was preferentially included because they studied more calcium channel inhibitors.	Vermes Birth Defects Res A Clin Mol Teratol 2015; 103:804-13 10.1002/bdra.23383